Senate Republicans to challenge auto safety mandates in January - WSJ
Synergy CHC Corporation reported its third-quarter earnings for 2025, showcasing a mixed financial performance. The company experienced a notable increase in net revenue but faced a decline in net income. Despite these mixed results, Synergy CHC remains optimistic about its future growth, particularly in the clean energy and brain health beverage sectors. The stock recently closed at $2.12, marking a 3.76% decline from the previous day.
Key Takeaways
- Synergy CHC's Q3 2025 net revenue rose by 12.4% year-over-year to $8 million.
- The company saw a significant drop in net income, down to $125,300 from $783,600 the previous year.
- The gross margin improved to 70.9% from 67.2% year-over-year.
- Synergy CHC is expanding its beverage distribution network, with new partnerships and product launches.
Company Performance
Synergy CHC Corporation reported a 12.4% increase in net revenue for the third quarter of 2025, reaching $8 million. This growth reflects the company's strategic focus on expanding its product distribution and entering new markets. However, net income dropped sharply to $125,300 from $783,600 in the same quarter last year, primarily due to increased operational costs and investments in product innovation.
Financial Highlights
- Revenue: $8 million, a 12.4% increase year-over-year.
- Earnings per share: $0.01, down from $0.11 the previous year.
- Gross margin: 70.9%, compared to 67.2% last year.
- Adjusted EBITDA: $1.52 million, a 13.4% increase from last year.
Outlook & Guidance
Synergy CHC is optimistic about its growth prospects in 2026, with plans to continue expanding its direct-to-store distribution network. The company is also focusing on securing additional distribution partnerships and launching new products in the clean energy and brain health segments. The strategic refinancing of its debt through 2029 is expected to provide financial stability and support its growth initiatives.
Executive Commentary
CEO Jack Ross highlighted the company's strategic focus, stating, "2025 has been a foundational year for Synergy." He emphasized the importance of adding key employees to support the company's growth ambitions and noted, "We are continuing to add key employees throughout our organization." Ross also expressed optimism about future distribution opportunities, remarking, "Timing is everything in life."
Risks and Challenges
- Supply Chain Issues: Potential disruptions could impact product availability and distribution timelines.
- Market Saturation: Increased competition in the clean energy and brain health sectors may affect market share.
- Macroeconomic Pressures: Economic downturns could reduce consumer spending on non-essential products.
- Operational Costs: Rising costs may continue to pressure net income margins.
Q&A
During the earnings call, analysts inquired about the contribution of Synergy CHC's beverage segment to overall revenue. Executives discussed plans for expanding distribution networks and highlighted price increases in the supplement business. Opportunities in direct store distribution networks were also a focal point of the discussion, with executives expressing confidence in leveraging these opportunities for future growth.
Full transcript - Synergy CHC Corp (SNYR) Q3 2025:
Carmen, Conference Call Operator: Good morning, everyone, and thank you for participating in today's conference call to discuss Synergy CHC Corporation's financial results for the third quarter ended September 30, 2025. Joining us today are Synergy's CEO, Jack Ross, CFO, Jaime Fickett, and Greg Robles with Investor Relations. Following their remarks, we'll open the call for analyst questions. Before we go further, I would like to turn the call over to Mr. Robles as he reads the company's Safe Harbor Statement. Greg, please go ahead.
Greg Robles, Investor Relations, Synergy CHC Corporation: Thanks, Carmen. Good morning, and thanks for joining our conference call to discuss our third quarter 2025 financial results. I'd like to remind everyone that this call is available for replay and via a live webcast that will be posted on our Investor Relations website at investors.synergychc.com. The information on this call contains forward-looking statements. These statements are often characterized by terminology such as believe, hope, may, anticipate, expect, will, and other similar expressions. Forward-looking statements are not guarantees of future performance, and the actual results may be materially different from the results implied by forward-looking statements. Factors that could cause results to differ materially from those implied herein include, but are not limited to, those factors disclosed in the company's SEC filings under the captioned risk factors.
The information on this call speaks only as of today's date, and the company disclaims any duty to update the information provided herein. Now, I would like to turn the call over to the CEO of Synergy, Jack Ross. Jack?
Jack Ross, CEO, Synergy CHC Corporation: Thank you, Greg. Good morning, everyone. Thank you for joining us today to discuss Synergy's performance for the third quarter of 2025. We are pleased to report our 11th consecutive quarter of profitability, reflecting our continued operational discipline and focused execution. Revenue, gross profit, and income from operations increased year over year, underscoring the strength of our platform as we scale across new categories and geographies. Before we get into the financial results, let me touch on a few key developments across our business. During the third quarter, we made important leadership additions to support our expanding operations. First, we welcome Teresa Thompson to our board of directors. Teresa spent nearly four decades at Costco Wholesale, including 29 years as a pharmacy OTC buyer, where she oversaw the vitamins and supplement categories across all U.S. warehouses.
Her insights and category experience will be invaluable as we scale Focus Factor brand globally and strengthen our supplement strategy. We also added Bob Anderson as our new Director of Direct Store Distribution, otherwise known as DSD. Bob has over 20 years' experience in the beverage industry, and he will be responsible for building and optimizing our nationwide direct-to-store distribution for our beverage division. With his extensive experience, we expect to be signing new distribution partners continually and rapidly. Moving to our functional beverage momentum, this business continues to accelerate for us and is supported by a growing national and international retail footprint. During the third quarter, we secured several major distribution wins that significantly expand our retail availability to our functional beverages and shops.
Looking at our domestic expansion, EG America, the sixth-largest convenience store chain in the U.S., will launch our Focus Energy beverages to over 1,600 high-traffic locations nationwide in Q4 of this year. The rollout meaningfully increases our visibility in the convenience channel and strengthens our position in the fast-growing functional beverage category. Additionally, Wakefern Food Group, the largest retailer-owned cooperative in the U.S., will carry five Focus Energy SKUs across 365 retail locations. On a regional front, we announced new partnerships with AlaBev, one of the premier beverage distributors in the Southeast U.S., who will distribute our beverages and Brain Health Shots to over 5,000 grocery, convenience, and specialty retailers across Alabama. We also signed an agreement with Atlantic Importing Company, a leading New England-based distributor, to expand our beverage footprint across Massachusetts, Connecticut, and Rhode Island.
These partnerships reflect strong validation from top-tier retailers and distributors who see the opportunity for the Focus Factor beverage to lead the clean energy and brain health beverage segment. As we continue to expand our beverage business, our focus remains on disciplined execution, brand awareness, and ensuring the availability of products in key markets that drive both volume and profitability. Turning to the supplement business, we continue to strengthen our momentum in this category as well. Focus Factor has recently been named the number one pharmacist-recommended OTC memory supplement for 2025-2026 by the Pharmacy Times. This underscores the confidence pharmacists place in our brand and our mission to deliver meaningful cognitive support to our consumers.
In the U.S., our supplement business expands with Kroger, one of America's largest supermarkets, operating in 35 states, which will launch three SKUs for the Focus Factor supplement across 1,600 of its 2,800 locations beginning in April of 2026. In Canada, Unipre, one of Quebec's largest pharmacy networks, will introduce the supplements across 300 stores beginning in February of 2026. Together, these launches expand our core brand presence across grocery and pharmacy channels, reinforcing our dual strategy of growing our supplements and beverages under the trusted Focus Factor banner. We also continue our international expansion. We have now received our first round of purchase orders from Costco, Mexico, for the Focus Factor supplements, which will ship in December in Q4.
Also, some of our management team is going to Dubai next week to meet with our licensing partner and attend the Middle East Organic Natural Products Expo, which will provide key contacts as we continue to develop our international footprint. Before passing the call over to Jaime to cover the financial results, I'd like to briefly touch on the public offering we closed in August. We raised $4.4 million of equity capital, which provides us with additional working capital to support our retail rollouts, inventory build-up, and production and marketing initiatives. This capital enhances our flexibility to meet rising demand and invest in our continued growth. Overall, the results reflect another strong quarter of execution, meaningful progress across both the beverage and supplement business, with new retail authorizations, expanded distribution partnerships, and experienced leadership people being added to our team.
Synergy is well-positioned to accelerate growth through the remainder of 2025 and into 2026. With that, I'll turn the call over to our Chief Financial Officer, Jaime Fickett. Jaime?
Jaime Fickett, CFO, Synergy CHC Corporation: Thank you, Jack. I'll now review our financial results. For the third quarter of 2025, net revenue was $8 million compared to $7.1 million in the year-ago quarter, reflecting an increase of 12.4%. Gross margin for the third quarter was 70.9% compared to 67.2% in the same quarter last year. The increase in gross margin was primarily driven by a favorable shift in product mix. Operating expenses for the third quarter were $4.4 million compared to $3.7 million in the year-ago quarter. The increase in operating expenses was primarily due to incremental costs associated with being a public company and the added cost of launching our beverage division. Income from operations was $1.28 million, up 21.8% from $1.05 million compared to the third quarter of 2024. Net income for the third quarter was $125,300 compared to $783,600 in the year-ago quarter.
Earnings per share for the third quarter was $0.01 per diluted share compared to $0.11 per diluted share in the year-ago quarter. Adjusted EBITDA per share for the third quarter was $0.15 per diluted share compared to $0.18 per diluted share in the year-ago quarter. These decreases are due to other income in the same period last year and higher expenses this year to launch the beverage division. EBITDA for the third quarter was $1.31 million, down 1.3% compared to $1.33 million in the third quarter of 2024. Adjusted EBITDA for the third quarter was $1.52 million, up 13.4% compared to $1.34 million in the third quarter of 2024. Moving to our balance sheet. As of September 30, 2025, we had cash and cash equivalents of $1 million compared to $687,900 as of December 31, 2024.
Inventory was $2.1 million at the end of the third quarter compared to $1.7 million at December 31, 2024, and we also have an increase in our prepaid deposits of nearly $2 million, largely due to an increase in deposits on inventory for our growing beverage division. At September 30, 2025, we have a working capital surplus of $16.68 million compared to a working capital deficit of $1.12 million as of December 31, 2024. For the nine months ended September 30, 2025, our cash used in operating activities was $3.21 million compared to cash used in operating activities of $1.38 million at September 30, 2024. The increase primarily reflects higher prepaid expenses for deposits on inventory and continued reductions in accounts payable and accrued liabilities. Now, I will turn the call back to the operator.
Carmen, Conference Call Operator: Thank you, ma'am. Now we will open the Q&A session. If you have a question, please press star 11 on your telephone and wait for your name to be announced. To withdraw your question, press star 11 again. Our first question will come from the line of Sean McGowan with Roth Capital Partners. Please proceed.
Sean McGowan, Analyst, Roth Capital Partners: Good morning, Jack. Good morning, Jaime. I have a couple of questions. Could you give us some sense of what contribution there was in the quarter from the beverages?
Jack Ross, CEO, Synergy CHC Corporation: In the current quarter, the third quarter was $159,000 of beverage revenue.
Sean McGowan, Analyst, Roth Capital Partners: Okay. That's helpful. Now, and that might explain or tie into the next question, which is, can you give me a little bit more color on the dynamics of the product mix? I mean, specifically, what is the highest margin revenue source, and how high is that in order for the blended average to come out pretty high? I think this is the highest you've seen in a while, right?
Jack Ross, CEO, Synergy CHC Corporation: Yeah. In our supplement business, we actually took a price increase to our Costco business of 11%, which I think our gross margin, our gross margin on our supplements, on gross revenue is about 75% before. It obviously increased that way. Our gross to net is about 11% of the difference. We basically took about an 11% increase in half of our business.
Sean McGowan, Analyst, Roth Capital Partners: Okay. Yeah. When I said it was the highest you've seen in a while, I meant factoring in the RTD. Anyway, last question is, is the G&A that you reported in the quarter indicative of what we should expect to see kind of at an ongoing rate, or given some of the executive additions that you've made that you highlighted at the top of the call, as well as some others, will the kind of fourth quarter and ongoing rate be higher than what we see in the third quarter?
Jack Ross, CEO, Synergy CHC Corporation: Good question, Sean. We sort of, we'll call, added a secondary strategy to our beverage rollout. With the sale of, we'll call, Poppy to Pepsi and the sale of Alani to Celsius, it really opened up, we'll call, a lot of holes in the DSD networks, meaning Poppy and Alani are going back to Pepsi distribution. We got very fortunate. Timing is everything in life. The DSD networks, the beer guys, have opened up a lot of holes in their distribution networks. Two things. Obviously, we expect to have an all-state strategy in our DSD network very quickly as we're signing these rapidly. You'll read about some more next week and the week after and the week after.
More importantly, to support those guys on the DSD side, we will be also adding human capital, salespeople, and service people to support those DSD distributors to bring on, we'll call, regional retailers. A little shift there where the opportunity presented itself with holes in the DSD distribution coming available, which should help us accelerate our RTD business a lot quicker than we thought in the convenience store side. There will be some, long way to say, there will be some added human capital in the fourth quarter and first quarter and second quarter as we expand that all-state DSD distribution.
Sean McGowan, Analyst, Roth Capital Partners: Okay. Thank you.
Carmen, Conference Call Operator: Thank you so much, and at this time, this concludes our Q&A session. I would like to turn the call back over to Mr. Ross for closing remarks.
Jack Ross, CEO, Synergy CHC Corporation: Thank you, Carmen. In closing, just a few final comments. We currently have over 3 million cans of drink inventory now in stock from our capital raise in August, with more production being done as we speak. We are continuing to add key employees throughout our organization to build out our sales network. 2025 has been a foundational year for Synergy between refinancing our debt out to 2029, raising equity to support our balance sheet and growth, and signing many key distribution partners and retailers. We feel that the team has positioned the company well for an exciting 2026. We thank everyone for joining the call today, and we look forward to speaking with everyone again in March when we announce our year-end results. Thank you.
Carmen, Conference Call Operator: Ladies and gentlemen, this does conclude today's conference. You may disconnect your lines at this time. Thank you for your participation.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.